A simple blood test, much like that used to detect tuberculosis, might identify as many as half of bladder cancer patients likely to fail intravesical bacillus Calmette-Guérin immunotherapy.
“This is more evidence that [dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin] is highly effective for patients with bladder cancer,” says researcher Scott M. Gilbert, MD, MS.
Men with AR-V7-positive prostate cancer seem to respond positively to a combination therapy with ipilimumab (Yervoy) and nivolumab (Opdivo).
Researchers studied data from a racially diverse cohort of 650 men undergoing a prostate biopsy between January 2007 and January 2018.
Practical strategies are available to help you collaborate, not compete.
Choices include playing the MIPS game or qualifying as an advanced APM.
Urologists can easily miss or disregard these important aspects of contracts, which could come back to haunt them.
Independence isn’t gone entirely in today’s urology practice environment, but it is different.
The oral beta-3 agonist vibegron, taken once daily at either 50 mg or 100 mg, is well tolerated and results in clinically and statistically significant reductions in daily micturitions, urge incontinence, and urgency episodes.
A nickel-sized leadless titanium device, implanted in patients’ ankles, could provide years of relief from overactive bladder syndrome.